Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of adjunctive cannabidiol oral solution in pediatric developmental and epileptic encephalopathy
2019-001633-14Phase 2Terminated
- Sponsor
- Ospedale Pediatrico Bambino Gesù
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cannabidiol in epileptic encephalopathy, sponsored by Ospedale Pediatrico Bambino Gesù. Started May 2021; status: terminated.
02
Drugs
cannabidiol
03
Conditions
epileptic encephalopathy
Beyond the preview
Go deeper on 2019-001633-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001633-14.